Summary of Cellebrite's Q2 2026 Earnings Call

1Key Financial Results and Metrics

Annual Recurring Revenue (ARR): Increased 21% year-over-year to $508 million, but missed guidance.

Revenue: Reported at $131 million, up 16% year-over-year; subscription revenue constituted 91% of total revenue.

Gross Profit: Increased 16% to $112 million, with a gross margin of 86%.

Adjusted EBITDA: $31.8 million, representing a 24% margin.

Net Income: $29.7 million, or $0.11 per diluted share.

Cash Position: Ended the quarter with $546 million in cash and equivalents; free cash flow for the trailing 12 months was $144.2 million (28% margin).

2Strategic Updates and Business Highlights

Leadership Change: Shiv Ramji appointed as CEO, succeeding Tom Hogan, to drive a product-centric strategy focused on cloud and AI.

Product Developments: New offerings like Guardian Investigate, Advanced Unlocks, and Genesis are gaining traction, contributing to ARR growth.

Federal Business Growth: Defense and Intelligence ARR grew 25%, with a strong pipeline for future opportunities.

Insights Conversion: Nearly 65% of the installed base has transitioned to the Insights digital forensic solution.

3Forward Guidance and Outlook

ARR Guidance: Lowered to $550 million - $560 million for FY 2026, reflecting a $15 million reduction at the midpoint.

Revenue Guidance: Adjusted to $555 million - $561 million, indicating 17% to 18% growth.

Adjusted EBITDA Target: Raised to $153 million - $159 million, representing a 28% margin.

Q3 Expectations: Anticipated ARR of $524 million - $528 million, with revenue projected between $145 million and $148 million.

4Bad News, Challenges, or Points of Concern

Sales Execution Issues: Q2 performance fell short due to delays in closing large transactions, particularly with U.S. federal and European government customers, attributed to new procurement requirements.

Insights Performance: Lower-than-expected ARR uplift from Insights conversions, particularly in the U.S. state and local government sector.

Longer Sales Cycles: Complicated cloud and AI deals are resulting in elongated sales cycles, with a noted average delay of approximately 6 weeks.

Foreign Entity Status: New administrative requirements related to foreign entity status have complicated procurement processes.

5Notable Q&A Insights

Confidence in Growth: Management emphasized that the current year is viewed as an execution reset rather than a long-term growth reset, citing early positive signals from product developments.

EMEA Challenges: Delays in transitioning major European customers to cloud solutions due to new EU laws on freedom of information were highlighted.

Pipeline Management: A thorough review of the pipeline has been initiated to enhance sales execution and forecasting accuracy.

Customer Cohort Dynamics: Insights conversions are being affected by a more conservative approach from customers, with a focus on ensuring that remaining customers transition effectively. Overall, while Cellebrite faces challenges in execution and market dynamics, the leadership transition and product innovations position the company for potential long-term growth.